Zheng Chen
No.910, Hengshan Road
Hengshan, 200030, China
Hengshan, 200030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
JAK2 inactivating mutations promotes endometrial cancer progression by targeting HIF-1α.
Journal: Discover oncology
Published: September 18, 2024
JAK1 inactivation promotes proliferation and migration of endometrial cancer cells via upregulating the hypoxia-inducible factor signaling pathway.
Journal: Cell communication and signaling : CCS
Published: August 14, 2022
Scutellarein induces apoptosis and inhibits proliferation, migration, and invasion in ovarian cancer via inhibition of EZH2/FOXO1 signaling.
Journal: Journal of biochemical and molecular toxicology
Published: September 14, 2020
Estrogen-ERα signaling and DNA hypomethylation co-regulate expression of stem cell protein PIWIL1 in ERα-positive endometrial cancer cells.
Journal: Cell communication and signaling : CCS
Published: January 21, 2020
Prostaglandin E2 (PGE2) promotes proliferation and invasion by enhancing SUMO-1 activity via EP4 receptor in endometrial cancer.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: February 17, 2016
Piwil1 causes epigenetic alteration of PTEN gene via upregulation of DNA methyltransferase in type I endometrial cancer.
Journal: Biochemical and biophysical research communications
Published: May 30, 2015
Mutant p53 induces EZH2 expression and promotes epithelial-mesenchymal transition by disrupting p68-Drosha complex assembly and attenuating miR-26a processing.
Journal: Oncotarget
Published: May 12, 2015
Stem cell protein Piwil1 endowed endometrial cancer cells with stem-like properties via inducing epithelial-mesenchymal transition.
Journal: BMC cancer
Published: January 28, 2015
Oncostatin M activates STAT3 to promote endometrial cancer invasion and angiogenesis.
Journal: Oncology reports
Published: January 11, 2015
Mutant p53 (p53-R248Q) functions as an oncogene in promoting endometrial cancer by up-regulating REGγ.
Journal: Cancer letters
Published: November 24, 2014
Suppression of the epithelial-mesenchymal transition by SHARP1 is linked to the NOTCH1 signaling pathway in metastasis of endometrial cancer.
Journal: BMC cancer
Published: February 25, 2014
Last Updated: 09/26/2026